Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;36(4):343-348.
doi: 10.1016/S1701-2163(15)30611-3.

Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?

Affiliations

Should doxylamine-pyridoxine be used for nausea and vomiting of pregnancy?

Navindra Persaud et al. J Obstet Gynaecol Can. 2014 Apr.

Abstract

Doxylamine-pyridoxine is the first-line agent for the treatment of nausea and vomiting of pregnancy (NVP) according to Canadian guidelines, and this combination is commonly prescribed to pregnant women. There is limited evidence that doxylamine-pyridoxine is more effective than pyridoxine alone. There is stronger support for the safety of pyridoxine monotherapy than for the combination of doxylamine-pyridoxine during pregnancy, and some conflicting evidence links doxylamine-pyridoxine use to pyloric stenosis and childhood malignancies. The role of doxylamine-pyridoxine as the first-line pharmacological treatment for NVP in Canada should be reconsidered.

La combinaison doxylamine-pyridoxine constitue l’agent de première intention à utiliser pour la prise en charge de la nausée et des vomissements de la grossesse (NVG), selon les lignes directrices canadiennes traitant de la question, et cette combinaison est couramment prescrite aux femmes enceintes. Les données qui indiquent que la combinaison doxylamine-pyridoxine est plus efficace que la pyridoxine utilisée seule sont limitées. En fait, les données qui soutiennent l’innocuité de la monothérapie à la pyridoxine pendant la grossesse sont plus solides que les données qui soutiennent celle de la combinaison doxylamine-pyridoxine; de plus, certaines données contradictoires établissent des liens entre la combinaison doxylamine-pyridoxine et les tumeurs malignes de l’enfance et la sténose du pylore. Le rôle de la combinaison doxylamine-pyridoxine à titre de traitement pharmacologique de première intention pour contrer la nausée et les vomissements de la grossesse au Canada devrait être remis en question.

Keywords: clinical practice guidelines; evidence-based medicine; nausea and vomiting of pregnancy.

PubMed Disclaimer

Publication types

LinkOut - more resources